Arbutus to Present at JMP Securities Life Sciences Conference

Arbutus Biopharma

WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company, announced that the Company will participate in a fireside chat at the JMP Securities Life Sciences Conference taking place in New York on Tuesday, May 16, 2023, at 9:00 am ET.

Presenters include William Collier, President & Chief Executive Officer; Dr. Michael Sofia, Chief Scientific Offer; and David Hastings, Chief Financial Officer

A live webcast of the fireside chat can be accessed through the Investors section of Arbutus’ website at www.arbutusbio.com. An archived replay of the webcast will be available on the Arbutus website after the event.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.

READ:  Panavance Therapeutics to Present at the Biotechnology Innovation Organization (BIO) International Convention